Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 909-709-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
Acute / short-term exposure - systemic and local effects
Inhalation:
As no local or systemic effects have been observed up to the maximal technically achievable concentration in the available acute inhalation toxicity studies with the reaction mass' constituents cerium dioxide and zirconium dioxide, no DNELs need to be derived.
However, it should be noted that for many countries/regions, occupational exposure limits have been derived for zirconium compounds after short-term exposure (e.g. typical STEL (Short Term Exposure Limit, 15 min) of 10 mg Zr/m3). Therefore, although it is considered reasonable not to derive DNELs, the relevant exposure limit should be checked and respected where relevant. Similarly, it should be checked if a STEL value has also been set for cerium (dioxide) and, should this be the case, this value should also be respected where relevant.
Dermal:
As no local or systemic effects have been observed in an acute dermal toxicity study with the reaction mass' constituent cerium dioxide at the limit test dose of 2000 mg/kg bw, no DNELs need to be derived. This is further supported by the fact that based on an acute oral toxicity study with the reaction mass, the substance does not meet the criteria for classification for acute toxicity or Specific Target Organ Toxicity following Single Exposure by the oral route and no systemic effects have been observed in in vivo studies with dermal exposure performed with the reaction mass (e.g., the in vivo skin irritation studies).
Long-term exposure - systemic and local effects
Inhalation:
The available repeated dose inhalation toxicity studies performed with nano or bulk cerium dioxide, with bulk zirconium dioxide, and with Zr-doped nano cerium dioxide did not indicate any signs of systemic toxicity. Therefore, no DNEL for systemic effects after repeated inhalation exposure should be set.
Zirconium dioxide, whether bulk or nano, is consistently found to be toxicologically inert, not resulting in loco-regional adverse effects in the lungs either. For cerium dioxide, whether bulk or nano, loco-regional adverse effects have been consistently observed in rats, but not in mouse. The observed loco-regional effects of cerium dioxide in rats are considered to represent rather a non-specific adaptive response to particle overload of the lung and indicate the sensitivity of rats to this type of condition (Ref. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. Inhalation Toxicology, 12: 1-17, 2000). Lung overload-related inflammatory response is commonly observed in rats following inhalation exposure to poorly soluble particles. The concept of overload applies specifically to poorly soluble particles with low cytotoxicity, such as cerium dioxide. The distribution of the retained particles within the lung compartments varies between species. It has been shown that during chronic inhalation exposure, particles are retained to a greater degree in interstitial locations in lungs of non-human primates and dogs than in lungs of rats, and that the interspecies differences in particle location might contribute to corresponding differences in tissue response (Ref. Snipes MB. Current information on lung overload in non-rodent mammals: contrast with rats. Inhalation Toxicology, 8(suppl): 91 -109, 1996). These differences combined with the fact that human macrophages have five times the volume of rat macrophages are considered to account for the tendency of rats to respond to poorly soluble particles with more chronic inflammation and epithelial responses compared to humans (Ref. Oberdörster G. Toxicokinetics and effects of fibrous and non-fibrous particles. Inhalation Toxicology, 14: 29-56, 2002). Therefore the observed loco-regional effects in rats are considered to be less relevant for humans and no DNEL for local effects after repeated inhalation exposure is set.
It should be noted that for many countries/regions, occupational exposure limits have been derived for zirconium compounds after long-term exposure (e.g. typical 8-h TWA (Time Weighted Average) of 5 mg Zr/m3). Therefore, although it is considered reasonable not to derive DNELs, the relevant exposure limit should be checked and respected where relevant. Similarly, it should be checked if an 8-h TWA value has also been set for cerium (dioxide) and, should this be the case, this value should also be respected where relevant. Further, it is recommended to also respect any relevant occupational exposure limit for respirable dust, where relevant.
Dermal:
No data are available that might indicate hazardous systemic or local effects after long-term dermal exposure. Therefore, no long-term DNELs are derived for this route of exposure.
Hazard for the eyes
The reaction mass of cerium dioxide and zirconium dioxide was concluded not to be hazardous for eyes, based on information from an in vivo eye irritation study performed with a representative nanoform of the reaction mass.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Acute / short-term exposure - systemic and local effects
Oral:
No local or systemic effects have been observed up to and including at the limit test dose of 2000 mg/kg bw in an acute oral toxicity study in rats performed with a representative nanoform of the reaction mass. Therefore, no DNELs need to be derived.
Inhalation:
As no local or systemic effects have been observed up to the maximal technically achievable concentration in the available acute inhalation toxicity studies with the reaction mass' constituents cerium dioxide and zirconium dioxide, no DNELs need to be derived.
Dermal:
As no local or systemic effects have been observed in an acute dermal toxicity study with the reaction mass' constituent cerium dioxide at the limit test dose of 2000 mg/kg bw, no DNELs need to be derived. This is further supported by the fact that based on an acute oral toxicity study with the reaction mass, the substance does not meet the criteria for classification for acute toxicity or Specific Target Organ Toxicity following Single Exposure by the oral route and no systemic effects have been observed in in vivo studies with dermal exposure performed with the reaction mass (e.g., the in vivo skin irritation studies).
Long-term exposure - systemic and local effects
Oral:
The available oral repeated dose toxicity studies with screening for reproductive/developmental toxicity (OECD 422) performed with cerium dioxide and zirconium acetate (i.e. a 'water soluble' zirconium compound which can be considered as representative - as a worst case - for the insoluble reaction mass' constituent zirconium dioxide) have not revealed any adverse systemic or local effects in parent animals, neither did they reveal adverse effects on reproduction/development. No adverse effects have been observed either in a 2-generation reproductive toxicity study performed with an organometallic nanoform of cerium dioxide (cerium and iron oxide isostearate). Therefore, no long-term oral DNELs need to be derived.
Inhalation:
The available repeated dose inhalation toxicity studies performed with nano or bulk cerium dioxide, with bulk zirconium dioxide, and with Zr-doped nano cerium dioxide did not indicate any signs of systemic toxicity. Therefore, no DNEL for systemic effects after repeated inhalation exposure should be set.
Zirconium dioxide, whether bulk or nano, is consistently found to be toxicologically inert, not resulting in loco-regional adverse effects in the lungs either. For cerium dioxide, whether bulk or nano, loco-regional adverse effects have been consistently observed in rats, but not in mouse. The observed loco-regional effects of cerium dioxide in rats are considered to represent rather a non-specific adaptive response to particle overload of the lung and indicate the sensitivity of rats to this type of condition (Ref. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. Inhalation Toxicology, 12: 1-17, 2000). Lung overload-related inflammatory response is commonly observed in rats following inhalation exposure to poorly soluble particles. The concept of overload applies specifically to poorly soluble particles with low cytotoxicity, such as cerium dioxide.The distribution of the retained particles within the lung compartments varies between species. It has been shown that during chronic inhalation exposure, particles are retained to a greater degree in interstitial locations in lungs of non-human primates and dogs than in lungs of rats, and that the interspecies differences in particle location might contribute to corresponding differences in tissue response (Ref. Snipes MB. Current information on lung overload in non-rodent mammals: contrast with rats. Inhalation Toxicology, 8(suppl): 91 -109, 1996). These differences combined with the fact that human macrophages have five times the volume of rat macrophages are considered to account for the tendency of rats to respond to poorly soluble particles with more chronic inflammation and epithelial responses compared to humans (Ref. Oberdörster G. Toxicokinetics and effects of fibrous and non-fibrous particles. Inhalation Toxicology, 14: 29-56, 2002). Therefore the observed loco-regional effects in rats are considered to be less relevant for humans and no DNEL for local effects is set.
Dermal:
No data are available that might indicate hazardous systemic or local effects after long-term dermal exposure. Therefore, no long-term DNELs are derived for this route of exposure.
Hazard for the eyes
The reaction mass of cerium dioxide and zirconium dioxide was concluded not to be hazardous for eyes, based on information from an in vivo eye irritation study performed with a representative nanoform of the reaction mass.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.